Article info
PDFParallel session 6: Clinical Neurology 2
181 Multiple Sclerosis associated with Psoriasis – is alemtuzumab the drug of choice?
Citation
181 Multiple Sclerosis associated with Psoriasis – is alemtuzumab the drug of choice?
Publication history
- First published November 14, 2019.
Online issue publication
April 06, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.